vs
Acadia Healthcare Company, Inc.（ACHC）与Simpson Manufacturing Co., Inc.（SSD）财务数据对比。点击上方公司名可切换其他公司
Acadia Healthcare Company, Inc.的季度营收约是Simpson Manufacturing Co., Inc.的1.4倍（$829.0M vs $588.0M），Simpson Manufacturing Co., Inc.净利率更高（15.0% vs 0.5%，领先14.5%），Simpson Manufacturing Co., Inc.同比增速更快（9.1% vs 7.5%），过去两年Acadia Healthcare Company, Inc.的营收复合增速更高（2.0% vs -0.8%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
辛普森制造是美国领先的建筑材料生产企业，主营面向新建建筑及改造翻新项目的结构连接件、紧固件、锚固件等专业产品，在建筑配套材料领域具备深厚的技术积累与较高的市场认可度。
ACHC vs SSD — 直观对比
营收规模更大
ACHC
是对方的1.4倍
$588.0M
营收增速更快
SSD
高出1.6%
7.5%
净利率更高
SSD
高出14.5%
0.5%
两年增速更快
ACHC
近两年复合增速
-0.8%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $829.0M | $588.0M |
| 净利润 | $4.5M | $88.2M |
| 毛利率 | — | 45.2% |
| 营业利润率 | — | 19.5% |
| 净利率 | 0.5% | 15.0% |
| 营收同比 | 7.5% | 9.1% |
| 净利润同比 | -50.8% | 13.3% |
| 每股收益（稀释后） | $0.05 | $2.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCSSD
| Q1 26 | $829.0M | $588.0M | ||
| Q4 25 | $821.5M | $539.3M | ||
| Q3 25 | $851.6M | $623.5M | ||
| Q2 25 | $869.2M | $631.1M | ||
| Q1 25 | $770.5M | $538.9M | ||
| Q4 24 | $774.2M | $517.4M | ||
| Q3 24 | $815.6M | $587.2M | ||
| Q2 24 | $796.0M | $597.0M |
净利润ACHCSSD
| Q1 26 | $4.5M | $88.2M | ||
| Q4 25 | $-1.2B | $56.2M | ||
| Q3 25 | $36.2M | $107.4M | ||
| Q2 25 | $30.1M | $103.5M | ||
| Q1 25 | $8.4M | $77.9M | ||
| Q4 24 | $32.6M | $55.4M | ||
| Q3 24 | $68.1M | $93.5M | ||
| Q2 24 | $78.5M | $97.8M |
毛利率ACHCSSD
| Q1 26 | — | 45.2% | ||
| Q4 25 | — | 43.4% | ||
| Q3 25 | — | 46.4% | ||
| Q2 25 | — | 46.7% | ||
| Q1 25 | — | 46.8% | ||
| Q4 24 | — | 44.0% | ||
| Q3 24 | — | 46.8% | ||
| Q2 24 | — | 46.7% |
营业利润率ACHCSSD
| Q1 26 | — | 19.5% | ||
| Q4 25 | -142.4% | 13.9% | ||
| Q3 25 | 4.7% | 22.6% | ||
| Q2 25 | 5.8% | 22.2% | ||
| Q1 25 | 1.7% | 19.0% | ||
| Q4 24 | 4.9% | 14.8% | ||
| Q3 24 | 12.1% | 21.3% | ||
| Q2 24 | 13.4% | 22.1% |
净利率ACHCSSD
| Q1 26 | 0.5% | 15.0% | ||
| Q4 25 | -143.3% | 10.4% | ||
| Q3 25 | 4.3% | 17.2% | ||
| Q2 25 | 3.5% | 16.4% | ||
| Q1 25 | 1.1% | 14.5% | ||
| Q4 24 | 4.2% | 10.7% | ||
| Q3 24 | 8.4% | 15.9% | ||
| Q2 24 | 9.9% | 16.4% |
每股收益（稀释后）ACHCSSD
| Q1 26 | $0.05 | $2.13 | ||
| Q4 25 | $-12.98 | $1.34 | ||
| Q3 25 | $0.40 | $2.58 | ||
| Q2 25 | $0.33 | $2.47 | ||
| Q1 25 | $0.09 | $1.85 | ||
| Q4 24 | $0.36 | $1.31 | ||
| Q3 24 | $0.74 | $2.21 | ||
| Q2 24 | $0.85 | $2.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $158.5M | $341.0M |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $2.0B | $2.1B |
| 总资产 | $5.5B | $3.0B |
| 负债/权益比越低杠杆越低 | 1.29× | — |
8季度趋势，按日历期对齐
现金及短期投资ACHCSSD
| Q1 26 | $158.5M | $341.0M | ||
| Q4 25 | $133.2M | $384.1M | ||
| Q3 25 | $118.7M | $297.3M | ||
| Q2 25 | $131.4M | $190.4M | ||
| Q1 25 | $91.2M | $150.3M | ||
| Q4 24 | $76.3M | $239.4M | ||
| Q3 24 | $82.1M | $339.4M | ||
| Q2 24 | $77.2M | $354.9M |
总债务ACHCSSD
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $300.0M | ||
| Q3 25 | $2.3B | $371.3M | ||
| Q2 25 | $2.3B | $376.9M | ||
| Q1 25 | $2.2B | $382.5M | ||
| Q4 24 | $2.0B | $388.1M | ||
| Q3 24 | $1.9B | $393.8M | ||
| Q2 24 | $1.8B | $399.4M |
股东权益ACHCSSD
| Q1 26 | $2.0B | $2.1B | ||
| Q4 25 | $1.9B | $2.0B | ||
| Q3 25 | $3.1B | $2.0B | ||
| Q2 25 | $3.1B | $1.9B | ||
| Q1 25 | $3.0B | $1.9B | ||
| Q4 24 | $3.1B | $1.8B | ||
| Q3 24 | $3.0B | $1.9B | ||
| Q2 24 | $3.0B | $1.8B |
总资产ACHCSSD
| Q1 26 | $5.5B | $3.0B | ||
| Q4 25 | $5.5B | $3.1B | ||
| Q3 25 | $6.4B | $3.0B | ||
| Q2 25 | $6.3B | $3.0B | ||
| Q1 25 | $6.1B | $2.8B | ||
| Q4 24 | $6.0B | $2.7B | ||
| Q3 24 | $5.9B | $2.9B | ||
| Q2 24 | $5.7B | $2.8B |
负债/权益比ACHCSSD
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 0.15× | ||
| Q3 25 | 0.74× | 0.19× | ||
| Q2 25 | 0.74× | 0.20× | ||
| Q1 25 | 0.72× | 0.21× | ||
| Q4 24 | 0.64× | 0.21× | ||
| Q3 24 | 0.62× | 0.21× | ||
| Q2 24 | 0.62× | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.5M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 13.78× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ACHCSSD
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $155.7M | ||
| Q3 25 | $73.2M | $170.2M | ||
| Q2 25 | $133.5M | $125.2M | ||
| Q1 25 | $11.5M | $7.6M | ||
| Q4 24 | $116.7M | $115.8M | ||
| Q3 24 | $163.1M | $103.3M | ||
| Q2 24 | $171.1M | $111.1M |
自由现金流ACHCSSD
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $119.0M | ||
| Q3 25 | $-63.0M | $133.9M | ||
| Q2 25 | $-34.2M | $87.3M | ||
| Q1 25 | $-163.2M | $-42.6M | ||
| Q4 24 | $-86.8M | $60.3M | ||
| Q3 24 | $-27.1M | $58.1M | ||
| Q2 24 | $16.9M | $70.9M |
自由现金流率ACHCSSD
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 22.1% | ||
| Q3 25 | -7.4% | 21.5% | ||
| Q2 25 | -3.9% | 13.8% | ||
| Q1 25 | -21.2% | -7.9% | ||
| Q4 24 | -11.2% | 11.7% | ||
| Q3 24 | -3.3% | 9.9% | ||
| Q2 24 | 2.1% | 11.9% |
资本支出强度ACHCSSD
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 6.8% | ||
| Q3 25 | 16.0% | 5.8% | ||
| Q2 25 | 19.3% | 6.0% | ||
| Q1 25 | 22.7% | 9.3% | ||
| Q4 24 | 26.3% | 10.7% | ||
| Q3 24 | 23.3% | 7.7% | ||
| Q2 24 | 19.4% | 6.7% |
现金转化率ACHCSSD
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 2.77× | ||
| Q3 25 | 2.02× | 1.58× | ||
| Q2 25 | 4.43× | 1.21× | ||
| Q1 25 | 1.37× | 0.10× | ||
| Q4 24 | 3.58× | 2.09× | ||
| Q3 24 | 2.39× | 1.10× | ||
| Q2 24 | 2.18× | 1.14× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
SSD
暂无分部数据
